RHBDF1 modulates cisplatin sensitivity of small cell lung cancer through YAP1/Smad2 signaling pathway

RHBDF1 modulates cisplatin sensitivity of small cell lung cancer through YAP1/Smad2 signaling pathway

Small cell lung cancer (SCLC) is a fatal tumor type that is prone to drug resistance. In our previous study, we showed that human rhomboid-5 homolog-1 (RHBDF1) was differentially expressed in 5 intrinsic cisplatin-resistant SCLC tissues compared with 5 intrinsic cisplatin-sensitive SCLC tissues by R...

Full description

Bibliographic Details
Main Authors: Lei Wang, Lishuang Qi, Xiaoyi Huang, Xiao Feng, Junqing Gan, Juxuan Zhang, Yuhui Xi, Shuai Zhang, Qingwei Meng
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Heliyon
Subjects:
RHBDF1
YAP1/Smad2 signaling
Chemoresistance
SCLC
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024094854

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024094854

Similar Items